Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


The Angels Initiative

Stroke prevention


  Pancreatitis

  Free Subscription


Articles published in Ann Surg

Retrieve available abstracts of 94 articles:
HTML format



Single Articles


    December 2022
  1. NISHIWADA S, Cui Y, Sho M, Jun E, et al
    Transcriptomic Profiling Identifies an Exosomal microRNA Signature for Predicting Recurrence Following Surgery in Patients With Pancreatic Ductal Adenocarcinoma.
    Ann Surg. 2022;276:e876-e885.
    PubMed     Abstract available


    November 2022
  2. KASLOW SR, Sacks GD, Berman RS, Lee AY, et al
    Natural History of Stage IV Pancreatic Cancer. Identifying Survival Benchmarks for Curative-intent Resection in Patients With Synchronous Liver-only Metastases.
    Ann Surg. 2022 Nov 10. pii: 00000658-990000000-00312.
    PubMed     Abstract available


    September 2022
  3. BALZANO G, Zerbi A, Aleotti F, Capretti G, et al
    Total Pancreatectomy with islet Autotransplantation as an Alternative to high-risk Pancreatojejunostomy after Pancreaticoduodenectomy: A Prospective Randomized Trial.
    Ann Surg. 2022 Sep 30. pii: 00000658-990000000-00269.
    PubMed     Abstract available


  4. JAVED AA, Ding D, Hasanain A, van Oosten F, et al
    Persistent Circulating Tumor Cells at One Year after Oncologic Resection Predict Late Recurrence in Pancreatic Cancer.
    Ann Surg. 2022 Sep 15. pii: 00000658-990000000-00263.
    PubMed     Abstract available


  5. JAVED AA, Floortje van Oosten A, Habib JR, Hasanain A, et al
    A Delay in Adjuvant Therapy is Associated with Worse Prognosis only in Patients with Transitional Circulating Tumor Cells Following Resection of Pancreatic Ductal Adenocarcinoma.
    Ann Surg. 2022 Sep 15. pii: 00000658-990000000-00264.
    PubMed     Abstract available


  6. DEMYAN L, Habowski AN, Plenker D, King DA, et al
    Pancreatic Cancer Patient-derived Organoids Can Predict Response to Neoadjuvant Chemotherapy.
    Ann Surg. 2022;276:450-462.
    PubMed     Abstract available


    August 2022
  7. KHACHFE HH, Nassour I, Hammad AY, Hodges JC, et al
    Robotic Pancreaticoduodenectomy: Increased Adoption and Improved Outcomes - Is Laparoscopy Still Justified?
    Ann Surg. 2022 Aug 24. pii: 00000658-990000000-00239.
    PubMed     Abstract available


  8. ECKER BL, Dickinson SM, Saadat LV, Tao AJ, et al
    Segmental vs. Diffuse Main Duct Intraductal Papillary Mucinous Neoplasm: Examination of Main Pancreatic Duct Morphology and Implications for Malignancy Risk and Extent of Surgical Resection.
    Ann Surg. 2022 Aug 11. pii: 00000658-990000000-00228.
    PubMed     Abstract available


  9. SEELEN LWF, Floortje van Oosten A, Brada LJH, Groot VP, et al
    Early Recurrence After Resection of Locally Advanced Pancreatic Cancer Following Induction Therapy: An International Multicenter Study.
    Ann Surg. 2022 Aug 11. pii: 00000658-990000000-00226.
    PubMed     Abstract available


  10. PARTELLI S, Muffatti F, Andreasi V, Giannone F, et al
    A Single-Center Prospective Observational Study Investigating the Accuracy of Preoperative Diagnostic Procedures in the Assessment of Lymph Node Metastases in Nonfunctioning Pancreatic Neuroendocrine Tumors.
    Ann Surg. 2022 Aug 5. pii: 00000658-990000000-00213.
    PubMed     Abstract available


  11. WEI AC, Jarnagin WR
    Prediction of R Status in Resections for Pancreatic Cancer Using Simplified Radiological Criteria: Not So Simple.
    Ann Surg. 2022;276:222-223.
    PubMed    


  12. BOLM L, Pisuchpen N, Qadan M, Kambadakone A, et al
    Prediction of R Status in Resections for Pancreatic Cancer Using Simplified Radiological Criteria.
    Ann Surg. 2022;276:215-221.
    PubMed     Abstract available


    July 2022
  13. MERDRIGNAC A, Garnier J, Dokmak S, Regenet N, et al
    Effect of the Use of Reinforced Stapling on the Occurrence of Pancreatic Fistula after Distal Pancreatectomy: Results of the REPLAY Multicenter Randomized clinical trial REPLAY: REinforcement of the Pancreas in distaL pAncreatectomY.
    Ann Surg. 2022 Jul 25. pii: 00000658-990000000-00185.
    PubMed     Abstract available


  14. BANNONE E, Marchegiani G, Vollmer C, Perri G, et al
    Postoperative Serum Hyperamylasemia (POH) Adds Sequential Value to the Fistula Risk Score (FRS) in Predicting Pancreatic Fistula after Pancreatoduodenectomy.
    Ann Surg. 2022 Jul 25. pii: 00000658-990000000-00182.
    PubMed     Abstract available


  15. TIMMERHUIS HC, van Dijk SM, Hollemans RA, Umans DS, et al
    Perforation and Fistula of the Gastrointestinal Tract in Patients with Necrotizing Pancreatitis: a Nationwide Prospective Cohort.
    Ann Surg. 2022 Jul 22. pii: 00000658-990000000-00174.
    PubMed     Abstract available


  16. SUURMEIJER JA, Henry AC, Bonsing BA, Bosscha K, et al
    Outcome of Pancreatic Surgery During the First Six Years of a Mandatory Audit within the Dutch Pancreatic Cancer Group.
    Ann Surg. 2022 Jul 22. pii: 00000658-990000000-00173.
    PubMed     Abstract available


  17. CHEN H, Wang C, Shen Z, Wang W, et al
    Post-pancreatectomy Acute Pancreatitis after Pancreaticoduodenectomy: A Distinct Clinical Entity.
    Ann Surg. 2022 Jul 18. pii: 00000658-990000000-00161.
    PubMed     Abstract available


  18. KINNY-KOSTER B, Habib JR, van Oosten AF, Javed AA, et al
    Conduits in Vascular Pancreatic Surgery: Analysis of Clinical Outcomes, Operative Techniques and Graft Performance.
    Ann Surg. 2022 Jul 15. pii: 00000658-990000000-00153.
    PubMed     Abstract available


  19. POULSON MR, Papageorge MV, LaRaja AS, Kenzik KM, et al
    Socioeconomic Mediation of Racial Segregation in Pancreatic Cancer Treatment and Outcome Disparities.
    Ann Surg. 2022 Jul 15. pii: 00000658-990000000-00136.
    PubMed     Abstract available


  20. HACKERT T, Klaiber U, Hinz U, Strunk S, et al
    Portal Vein Resection in Pancreatic Cancer Surgery: Risk of Thrombosis and Radicality Determine Survival.
    Ann Surg. 2022 Jul 6. pii: 00000658-990000000-00058.
    PubMed     Abstract available


  21. YAO J, Cao K, Hou Y, Zhou J, et al
    Deep Learning for Fully Automated Prediction of Overall Survival in Patients Undergoing Resection for Pancreatic Cancer: A Retrospective Multicenter Study.
    Ann Surg. 2022 Jul 4. pii: 00000658-990000000-00053.
    PubMed     Abstract available


    June 2022
  22. CHINNAKOTLA S, Beilman GJ, Vock D, Freeman ML, et al
    Intraportal Islet Autotransplantation Independently Improves Quality of Life after Total Pancreatectomy in Patients with Chronic Refractory Pancreatitis.
    Ann Surg. 2022 Jun 28. pii: 00000658-990000000-00030.
    PubMed     Abstract available


  23. HANK T, Klaiber U, Hinz U, Schutte D, et al
    Oncological Outcome of Conversion Surgery After Preoperative Chemotherapy for Metastatic Pancreatic Cancer.
    Ann Surg. 2022 Jun 27. pii: 00000658-990000000-00016.
    PubMed     Abstract available


  24. BOLM L, Nebbia M, Wei AC, Zureikat AH, et al
    Long Term Outcomes of Parenchyma-Sparing and Oncologic Resections in Patients with Non-Functional Pancreatic Neuroendocrine Tumors <3cm in a Large Multi-Center Cohort.
    Ann Surg. 2022 Jun 27. pii: 00000658-990000000-00029.
    PubMed     Abstract available


    March 2022
  25. YAMAGUCHI J, Yokoyama Y, Fujii T, Yamada S, et al
    Results of a Phase II Study on the use of Neoadjuvant Chemotherapy (FOLFIRINOX or Gemcitabine with nab-paclitaxel) for Borderline-Resectable Pancreatic Cancer (NUPAT-01).
    Ann Surg. 2022 Mar 3. pii: 00000658-900000000-93060.
    PubMed     Abstract available


  26. DA COSTA WL JR, Tran Cao HS, Gu X, Massarweh NN, et al
    Bayesian Approach to Understand the Association Between Treatment Down-staging and Survival for Patients With Pancreatic Adenocarcinoma.
    Ann Surg. 2022;275:415-421.
    PubMed     Abstract available


  27. SCHULICK RD
    Commentary on "Laparoscopic Pancreaticoduodenectomy With Transanal Specimen Extraction for Periampullary Tumors".
    Ann Surg. 2022;275:e599.
    PubMed    


    February 2022
  28. BOECK S, Heinemann V, Werner J
    Comment on "Detection, Treatment, and Survival of Pancreatic Cancer Recurrence in the Netherlands: A Nationwide Analysis".
    Ann Surg. 2022 Feb 1. pii: 00000658-900000000-93084.
    PubMed    


  29. DAAMEN LA, Groot VP, Verkooijen HM, Molenaar IQ, et al
    Response to: Comment on "Detection, Treatment, and Survival of Pancreatic Cancer Recurrence in the Netherlands: A Nationwide Analysis".
    Ann Surg. 2022 Feb 1. pii: 00000658-900000000-93083.
    PubMed    


    January 2022
  30. JAVED AA, Pulvirenti A, Razi S, Zheng J, et al
    Grading Pancreatic Neuroendocrine Tumors via Endoscopic Ultrasound-guided Fine Needle Aspiration: A Multi-Institutional Study.
    Ann Surg. 2022 Jan 25. pii: 00000658-900000000-93105.
    PubMed     Abstract available


  31. OMIYA K, Oba A, Inoue Y, Kobayashi K, et al
    Serum DUPAN-2 could be an Alternative Biological Marker for CA19-9 Non-secretors with Pancreatic Cancer.
    Ann Surg. 2022 Jan 25. pii: 00000658-900000000-93098.
    PubMed     Abstract available



  32. Root-cause Analysis of Mortality After Pancreatic Resection (CARE Study): A Multicenter Cohort Study: Erratum.
    Ann Surg. 2022;275:e280.
    PubMed    


    December 2021
  33. JANSSEN BV, Verhoef S, Wesdorp NJ, Huiskens J, et al
    Imaging-based Machine-learning Models to Predict Clinical Outcomes and Identify Biomarkers in Pancreatic Cancer: A Scoping Review.
    Ann Surg. 2021 Dec 23. pii: 00000658-900000000-93137.
    PubMed     Abstract available


  34. LOPEZ-VERDUGO F, Fong ZV, Lillemoe KD, Blaszkowsky LS, et al
    Underlying Bias in the Treatment of Pancreatic Cancer: Minorities Treated at the Same Facilities are Less Likely to Receive Neoadjuvant Therapy.
    Ann Surg. 2021 Dec 23. pii: 00000658-900000000-93135.
    PubMed     Abstract available


  35. NAGAKAWA Y, Jang JY, Kawai M, Kim SC, et al
    Surgical Outcomes of Pancreatectomy with Resection of the Portal Vein and/or Superior Mesenteric Vein and Jejunal Vein for Pancreatic Head Cancer: A Multicenter Study.
    Ann Surg. 2021 Dec 14. pii: 00000658-900000000-93153.
    PubMed     Abstract available


  36. CLARKE CN, Maduekwe UN
    Commentary on Brief Clinical Report: "Coronary Artery Stent for Securing High-risk Pancreatico-jejunal Anastomosis After Pancreaticoduodenectomy: A pilot series".
    Ann Surg. 2021 Dec 14. pii: 00000658-900000000-93145.
    PubMed    


  37. HUANG L, Jansen L, Balavarca Y, van der Geest L, et al
    Significance of Examined Lymph Node Number in Accurate Staging and Long-term Survival in Resected Stage I-II Pancreatic Cancer-More is Better? A Large International Population-based Cohort Study.
    Ann Surg. 2021;274:e554-e563.
    PubMed     Abstract available


    November 2021
  38. BEDNAR F
    Clinical Staging Uncertainty and Treatment Sequencing in Pancreatic Cancer.
    Ann Surg. 2021 Nov 18. pii: 00000658-900000000-93186.
    PubMed    


  39. HUSCHER C, Perri G, Lazzarin G, Marchegiani G, et al
    Coronary Artery Stent for Securing High-risk Pancreatico-jejunal Anastomosis After Pancreatoduodenectomy: A Pilot Series.
    Ann Surg. 2021 Nov 18. pii: 00000658-900000000-93185.
    PubMed     Abstract available


  40. GARAJOVA I, Balsano R, Donati V, Gnetti L, et al
    Comment on "Implications of Perineural Invasion on Disease Recurrence and Survival After Pancreatectomy for Pancreatic Head Ductal Adenocarcinoma by Crippa et al."
    Ann Surg. 2021 Nov 11. pii: 00000658-900000000-93189.
    PubMed    


  41. DAYYEH BKA, Chandrasekhara V, Shah RJ, Easler JJ, et al
    Combined Drainage and Protocolized Necrosectomy Through a Co-axial Lumen-Apposing Metal Stent for Pancreatic Walled-off Necrosis: A Prospective Multicenter Trial.
    Ann Surg. 2021 Nov 2. pii: 00000658-900000000-93212.
    PubMed     Abstract available


    October 2021
  42. KEMPENEERS MA, Issa Y, Bruno MJ, van Santvoort HC, et al
    Cost-Effectiveness of Early Surgery Versus Endoscopy-First Approach for Painful Chronic Pancreatitis in the ESCAPE Trial.
    Ann Surg. 2021 Oct 8. pii: 00000658-900000000-93237.
    PubMed     Abstract available


  43. DALMACY D, Paro A, Hyer JM, Obeng-Gyasi S, et al
    Association of County-level Upward Economic Mobility with Stage at Diagnosis and Receipt of Treatment Among Patients Diagnosed with Pancreatic Adenocarcinoma.
    Ann Surg. 2021 Oct 8. pii: 00000658-900000000-93235.
    PubMed     Abstract available


    September 2021
  44. MARCHEGIANI G, Barreto SG, Bannone E, Sarr M, et al
    Postpancreatectomy Acute Pancreatitis (PPAP): Definition and Grading from the International Study Group for Pancreatic Surgery (ISGPS).
    Ann Surg. 2021 Sep 29. pii: 00000658-900000000-93261.
    PubMed     Abstract available


    August 2021
  45. LIU Q, Zhao Z, Zhang X, Wang W, et al
    Perioperative and Oncological Outcomes of Robotic Versus Open Pancreaticoduodenectomy in Low-Risk Surgical Candidates: A Multicenter Propensity Score-Matched Study.
    Ann Surg. 2021 Aug 19. pii: 00000658-900000000-93318.
    PubMed     Abstract available


  46. ROLDAN J, Harrison JM, Qadan M, Bolm L, et al
    "Evolving Trends in Pancreatic Cystic Tumors: A 3-Decade Single-Center Experience with 1290 Resections".
    Ann Surg. 2021 Aug 4. pii: 00000658-900000000-93359.
    PubMed     Abstract available


    July 2021
  47. BIRRER DL, Golcher H, Casadei R, Haile SR, et al
    Neoadjuvant Therapy for Resectable Pancreatic Cancer: A New Standard of Care. Pooled Data from Three Randomized Controlled Trials.
    Ann Surg. 2021 Jul 29. pii: 00000658-900000000-93387.
    PubMed     Abstract available


  48. BEUGNIEZ C, Sauvanet A, Sulpice L, Gaujoux S, et al
    Root-Cause Analysis of Mortality Following Pancreatic Resection (CARE Study): A Multicenter Cohort Study.
    Ann Surg. 2021 Jul 29. pii: 00000658-900000000-93374.
    PubMed     Abstract available


  49. BRADA LJH, Daamen LA, Magermans LG, Walma MS, et al
    Survival Benefit Associated With Resection of Locally Advanced Pancreatic Cancer Following Upfront FOLFIRINOX versus FOLFIRINOX Only: Multicenter Propensity Score-Matched Analysis.
    Ann Surg. 2021 Jul 29. pii: 00000658-900000000-93372.
    PubMed     Abstract available


  50. JOLISSAINT JS, Reyngold M, Bassmann J, Seier KP, et al
    Local Control and Survival after Induction Chemotherapy and Ablative Radiation Versus Resection for Pancreatic Ductal Adenocarcinoma with Vascular Involvement.
    Ann Surg. 2021 Jul 16. pii: 00000658-900000000-93409.
    PubMed     Abstract available


  51. MAATMAN TK, McGuire SP, Flick KF, Madison MK, et al
    Outcomes in Endoscopic and Operative Transgastric Pancreatic Debridement.
    Ann Surg. 2021 Jul 7. pii: 00000658-900000000-93434.
    PubMed     Abstract available


  52. YEO TP, Fogg RW, Shimada A, Marchesani N, et al
    The Imperative of Assessing Quality of Life in Patients Presenting to a Pancreaticobiliary Surgery Clinic.
    Ann Surg. 2021 Jul 2. pii: 00000658-900000000-93452.
    PubMed     Abstract available


  53. BLAIR AB, Yin LD, Pu N, Yu J, et al
    Recurrence in Patients Achieving Pathological Complete Response After Neoadjuvant Treatment for Advanced Pancreatic Cancer.
    Ann Surg. 2021;274:162-169.
    PubMed     Abstract available


    June 2021
  54. HESTER CA, Kothari AN, Mason M, Maxwell J, et al
    Surgical Eligibility Does Not Imply Surgical Equity: Recommendations for Curative Treatment in Patients with Stage I/II Pancreatic Head Adenocarcinoma Differ by Age and Race.
    Ann Surg. 2021 Jun 25. pii: 00000658-900000000-93456.
    PubMed     Abstract available


  55. DAI M, Liu Q, Xing C, Tian X, et al
    Early Drain Removal is Safe in Patients With Low or Intermediate Risk of Pancreatic Fistula After Pancreaticoduodenectomy: A Multicenter, Randomized Controlled Trial.
    Ann Surg. 2021 Jun 11. pii: 00000658-900000000-93510.
    PubMed     Abstract available


    April 2021
  56. BANNONE E, Marchegiani G, Balduzzi A, Procida G, et al
    Early and Sustained Elevation in Serum Pancreatic Amylase Activity: A Novel Predictor of Morbidity after Pancreatic Surgery.
    Ann Surg. 2021 Apr 30. pii: 00000658-900000000-93565.
    PubMed     Abstract available


  57. GIULIANI T, De Pastena M, Paiella S, Marchegiani G, et al
    Pancreatic Enucleation Patients Share the Same Quality of Life as the General Population at Long-Term Follow-Up: A Propensity-Score Matched Analysis.
    Ann Surg. 2021 Apr 14. pii: 00000658-900000000-93588.
    PubMed     Abstract available


  58. HABIB JR, Kinny-Koster B, Bou-Samra P, Alsaad R, et al
    Surgical Decision Making in Pancreatic Ductal Adenocarcinoma: Modeling Prognosis Following Pancreatectomy in the Era of Induction and Neoadjuvant Chemotherapy.
    Ann Surg. 2021 Apr 9. pii: 00000658-900000000-93602.
    PubMed     Abstract available


  59. MENG H, Wang S, Liu J, Zhao X, et al
    Laparoscopic Pancreaticoduodenectomy with Transanal Specimen Extraction for Periampullary Tumors.
    Ann Surg. 2021 Apr 7. pii: 00000658-900000000-93576.
    PubMed     Abstract available


  60. HACKERT T, Buchler MW
    Respone to: Comment on Prognostic Factors of Survival After Neoadjuvant Treatment and Resection for Initially Unresectable Pancreatic Cancer.
    Ann Surg. 2021 Apr 1. doi: 10.1097/SLA.0000000000004872.
    PubMed    


  61. LINDEMANN J, Toit LD, Krige J, Jonas E, et al
    Comment on: Prognostic Factors of Survival After Neoadjuvant Treatment and Resection for Initially Unresectable Pancreatic Cancer.
    Ann Surg. 2021 Apr 1. doi: 10.1097/SLA.0000000000004877.
    PubMed    


    March 2021
  62. SCHUH F, Mihaljevic AL, Probst P, Trudeau MT, et al
    A Simple Classification Of Pancreatic Duct Size and Texture Predicts Postoperative Pancreatic Fistula: A classification of the International Study Group of Pancreatic Surgery (ISGPS).
    Ann Surg. 2021 Mar 12. doi: 10.1097/SLA.0000000000004855.
    PubMed     Abstract available


  63. MARCHEGIANI G, Perri G, Burelli A, Zoccatelli F, et al
    High-risk Pancreatic Anastomosis vs. Total Pancreatectomy after Pancreatoduodenectomy: Postoperative Outcomes and Quality of Life Analysis.
    Ann Surg. 2021 Mar 4. doi: 10.1097/SLA.0000000000004840.
    PubMed     Abstract available


  64. HANK T, Hinz U, Reiner T, Malleo G, et al
    A Pretreatment Prognostic Score to Stratify Survival in Pancreatic Cancer.
    Ann Surg. 2021 Mar 4. doi: 10.1097/SLA.0000000000004845.
    PubMed     Abstract available


    February 2021
  65. LOOS M, Hackert T, Buchler MW
    Response to Comment on "Arterial Resection in Pancreatic Cancer Surgery: Effective After a Learning Curve".
    Ann Surg. 2021 Feb 10. pii: 00000658-900000000-93709.
    PubMed    


  66. REAMES BN, Ejaz A, Weiss MJ
    Comment on "Arterial Resection in Pancreatic Cancer Surgery: Effective After a Learning Curve".
    Ann Surg. 2021 Feb 10. pii: 00000658-900000000-93707.
    PubMed    


    January 2021
  67. BEGER HG, Mayer B, Vasilescu C, Poch B, et al
    Long-term Metabolic Morbidity and Steatohepatosis Following Standard Pancreatic Resections and Parenchyma-sparing, Local Extirpations for Benign Tumor: A Systematic Review and Meta-analysis.
    Ann Surg. 2021 Jan 15. doi: 10.1097/SLA.0000000000004757.
    PubMed     Abstract available


  68. VAN DEN BERG FF, Issa Y, Vreijling JP, Lerch MM, et al
    Whole-Exome Sequencing Identifies SLC52A1 and ZNF106 Variants as Novel Genetic Risk Factors for (Early) Multiple-Organ Failure in Acute Pancreatitis.
    Ann Surg. 2021;Publish Ahead of Print.
    PubMed     Abstract available


  69. ADDEO P, Averous G, Bachellier P
    Response to Comment on "Pancreatectomy With Arterial Resection for Pancreatic Adenocarcinoma: How Can It Be Done Safely and With Which Outcomes?"
    Ann Surg. 2021 Jan 1. pii: 00000658-900000000-93782.
    PubMed    


    December 2020
  70. QING Z, Liu ZY, Chen QY, Huang CM, et al
    Comment on: Significance of Lymph Node Resection After Neoadjuvant Therapy in Pancreatic, Gastric, and Rectal Cancers.
    Ann Surg. 2020 Dec 29. doi: 10.1097/SLA.0000000000004734.
    PubMed    


  71. HEWITT DB, Nissen N, Hatoum H, Musher B, et al
    A Phase 3 Randomized Clinical Trial of Chemotherapy With or Without Algenpantucel-L (HyperAcute-Pancreas) Immunotherapy in Subjects with Borderline Resectable or Locally Advanced Unresectable Pancreatic Cancer.
    Ann Surg. 2020 Dec 22. doi: 10.1097/SLA.0000000000004669.
    PubMed     Abstract available


  72. GIBOR U, Perry Z, Netz U, Kirshtein B, et al
    Circulating Cell-free DNA in Patients with Acute Biliary Pancreatitis: Association with Disease Markers and Prolonged Hospitalization Time-A Prospective Cohort Study.
    Ann Surg. 2020;Publish Ahead of Print.
    PubMed     Abstract available


  73. SUGUMAR K, Hue JJ, Ahorukomeye P, Rothermel LD, et al
    Defining Common Features in High Impact and Highly Cited Journal Articles on Pancreatic Tumors: An Analysis of 1044 Studies over the Past Decade.
    Ann Surg. 2020;Publish Ahead of Print.
    PubMed     Abstract available


  74. DE GEUS SWL, Hachey KJ, Nudel JD, Ng SC, et al
    Volume of Pancreas-Adjacent Operations Favorably Influences Pancreaticoduodenectomy Outcomes at Lower Volume Pancreas Centers.
    Ann Surg. 2020 Dec 2. doi: 10.1097/SLA.0000000000004432.
    PubMed     Abstract available


  75. VERSTEIJNE E, Suker M, Groen JV, Besselink MG, et al
    External Validity of the Multicenter Randomized PREOPANC Trial on Neoadjuvant Chemoradiotherapy in Pancreatic Cancer: Outcome of Eligible But Non-Randomized Patients.
    Ann Surg. 2020 Dec 2. doi: 10.1097/SLA.0000000000004364.
    PubMed     Abstract available


    November 2020
  76. HUNGER R, Mantke R
    Outcome Quality Beyond the Mean - An Analysis of 43,231 Pancreatic Surgical Procedures Related to Hospital Volume.
    Ann Surg. 2020 Nov 23. doi: 10.1097/SLA.0000000000004315.
    PubMed     Abstract available


  77. LOF S, Korrel M, Besselink MG, Abu Hilal M, et al
    Response to Comment on "Outcomes of Elective and Emergency Conversion in Minimally Invasive Distal Pancreatectomy for Pancreatic Ductal Adenocarcinoma: An International Multicenter Propensity Score-matched Study".
    Ann Surg. 2020 Nov 23. doi: 10.1097/SLA.0000000000004279.
    PubMed    


  78. CHEN B, Li G, Cheng W, Chen M, et al
    Comment On: Colon Involvement in Necrotizing Pancreatitis: Incidence, Risk Factors, and Outcomes.
    Ann Surg. 2020 Nov 17. doi: 10.1097/SLA.0000000000004621.
    PubMed    


  79. ZYROMSKI NJ, Maatman TK
    Response to Letter to Editor Regarding: "Colon Involvement in Necrotizing Pancreatitis: Incidence, Risk Factors, and Outcomes" (Ann Surg 2020 Jul 7. Online Ahead of Print; PMID: 32649468).
    Ann Surg. 2020 Nov 17. doi: 10.1097/SLA.0000000000004622.
    PubMed    


  80. ROBERTSON FP, Ravikumar R, Wigmore SJ
    Comment on: Pancreatectomy With Arterial Resection for Pancreatic Adenocarcinoma: How Can It Be Done Safely and With Which Outcomes?
    Ann Surg. 2020 Nov 17. doi: 10.1097/SLA.0000000000004536.
    PubMed    


  81. ZHANG XP, Zhao GD, Liu R
    Comment On "Pancreatectomy With Arterial Resection for Pancreatic Adenocarcinoma: How Can It Be Done Safely and With Which Outcomes?"
    Ann Surg. 2020 Nov 16. doi: 10.1097/SLA.0000000000004410.
    PubMed    


  82. RAMIREZ-MALDONADO E, Gordo SL, Pueyo EM, Sanchez-Garcia A, et al
    Immediate Oral Refeeding in Patients With Mild and Moderate Acute Pancreatitis: A Multicenter, Randomized Controlled Trial (PADI trial).
    Ann Surg. 2020 Nov 13. doi: 10.1097/SLA.0000000000004596.
    PubMed     Abstract available


  83. VAN DONGEN JC, Suker M, Versteijne E, Bonsing BA, et al
    Surgical Complications in a Multicenter Randomized Trial Comparing Preoperative Chemoradiotherapy and Immediate Surgery in Patients With Resectable and Borderline Resectable Pancreatic Cancer (PREOPANC Trial).
    Ann Surg. 2020 Nov 12. doi: 10.1097/SLA.0000000000004313.
    PubMed     Abstract available


  84. MALLEO G, Maggino L, Qadan M, Marchegiani G, et al
    Reassessment of the Optimal Number of Examined Lymph Nodes in Pancreatoduodenectomy for Pancreatic Ductal Adenocarcinoma.
    Ann Surg. 2020 Nov 9. doi: 10.1097/SLA.0000000000004552.
    PubMed     Abstract available


    October 2020
  85. HUANG L
    Response to the: Comment on "Optimal Number of Examined Lymph Node May Depend on Age in Patients with Pancreatic Adenocarcinoma".
    Ann Surg. 2020 Oct 19. doi: 10.1097/SLA.0000000000004449.
    PubMed    


  86. CRIPPA S, Pergolini I, Javed AA, Honselmann KC, et al
    Implications of Perineural Invasion on Disease Recurrence and Survival After Pancreatectomy for Pancreatic Head Ductal Adenocarcinoma.
    Ann Surg. 2020 Oct 19. doi: 10.1097/SLA.0000000000004464.
    PubMed     Abstract available


  87. DATTA J, Wilson GC, D'Angelica MI, Katz MH, et al
    A Call for Caution in Overinterpreting Exceptional Outcomes Following Radical Surgery for Pancreatic Cancer: Let the Data Speak.
    Ann Surg. 2020 Oct 19. doi: 10.1097/SLA.0000000000004471.
    PubMed    


  88. MAATMAN TK, Ceppa EP, Fogel EL, Easler JJ, et al
    Biliary Stricture after Necrotizing Pancreatitis: An Underappreciated Challenge.
    Ann Surg. 2020 Oct 19. doi: 10.1097/SLA.0000000000004470.
    PubMed     Abstract available


  89. CHAWLA A, Qadan M, Castillo CF, Wo JY, et al
    Prospective Phase II Trials Validate the Effect of Neoadjuvant Chemotherapy on Pattern of Recurrence in Pancreatic Adenocarcinoma.
    Ann Surg. 2020 Oct 19. doi: 10.1097/SLA.0000000000004585.
    PubMed     Abstract available


  90. XU HX, Li S, Xu SS, Liu L, et al
    Comments on "Importance of Normalization of CA19-9 Levels Following Neoadjuvant Therapy in Patients with Localized Pancreatic Cancer".
    Ann Surg. 2020 Oct 15. doi: 10.1097/SLA.0000000000004538.
    PubMed    


  91. TAKAHASHI S, Ohno I, Ikeda M, Konishi M, et al
    Neoadjuvant S-1 With Concurrent Radiotherapy Followed by Surgery for Borderline Resectable Pancreatic Cancer: A Phase II Open-Label Multicenter Prospective Trial (JASPAC05).
    Ann Surg. 2020 Oct 15. doi: 10.1097/SLA.0000000000004535.
    PubMed     Abstract available


  92. SCHULICK RD, Oba A, Del Chiaro M
    Response to the Comment on "Prognosis-based Definition of Resectability in Pancreatic Cancer: A Road Map to New Guidelines".
    Ann Surg. 2020 Oct 14. doi: 10.1097/SLA.0000000000004275.
    PubMed    


    September 2020
  93. HU HJ, Cheng NS, Li FY
    Comment on: Outcomes of Elective and Emergency Conversion in Minimally Invasive Distal Pancreatectomy for Pancreatic Ductal Adenocarcinoma: An International Multicenter Propensity Score-matched Study.
    Ann Surg. 2020 Sep 29. doi: 10.1097/SLA.0000000000004283.
    PubMed    


    June 2020
  94. LOOS M, Kester T, Klaiber U, Mihaljevic AL, et al
    Arterial Resection in Pancreatic Cancer Surgery: Effective After a Learning Curve.
    Ann Surg. 2020 Jun 12. doi: 10.1097/SLA.0000000000004054.
    PubMed     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Pancreatitis is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: